Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...

Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant ...

Johnson & Johnson has secured European approval for the subcutaneous formulation of Darzalex, combined with bortezomib, lenalidomide, and dexamethasone, for newly diagnosed multiple myeloma patients ...

Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ...

J&J reported overall revenues up 4.3% to $22.4 billion in the second quarter, fuelled by growth for blood cancer therapy Darzalex (daratumumab) and particularly subcutaneous version Darzalex ...

That extends the use of the drug in relapsed or refractory disease – for which it has been FDA-approved since 2020 – and makes it the first anti-CD38 competition to Darzalex (daratumumab ...

In separate, live virtual events, Doris Hansen, MD, and Leyla O. Shune, MD, discuss options for a patient with ...

Israel struck military bases but avoided targeting nuclear facilities. Iran has so far largely played down the attack, but now faces a decision about how to respond. Paramilitary forces ransacked ...

The 47-year-old reservist from Kibbutz Mevo Hama, left behind his wife Dafna, daughters, Mika and Gaya, and son Amit, according to Ynet. Information ...

The change negotiations that started on 4 September 2024 covered approximately 220 people. At the beginning of the negotiations, the planned measures were estimated to lead to the termination of up to ...